The latest round of funding raised by Immunic, Inc. is expected to strongly support the company's strategic transformation—from a biotechnology enterprise focused on research and development to a fully integrated commercial entity with a complete industry chain.

老虎证券2026/02/13 11:56

Show original

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Star: Rumors of an exchange hack are false

AiCoin•2026/10/31 05:45

Ozzy: StepDrainer attack expands to multiple DeFi projects

AiCoin•2026/10/31 03:47

The annualized deposit yield is 9.58%, Pendle launches its second ecosystem vault on Morpho.

Odaily星球日报•2026/10/31 01:47

France's fiscal outlook deteriorates as Fitch revises rating outlook to negative

Due to the deterioration of public finances, including slower growth, rising borrowing costs, and widening deficits, Fitch Ratings has revised France's credit rating outlook to negative.

智通财经•2026/10/31 01:46